4 min read
What is a Scientific & Medical Publications Professional?
Would your drug development program benefit from partnering with experts in scientific and medical communications and...
Join Veristat and ACER Therapeutics at the VEDS Scientific Meeting Day 2022
ACER Therapeutics Decentralized Study Design: A Phase 3 Clinical Study in Patients with COL3A1-Positive Vascular Ehlers-Danlos Syndrome to Determine Whether Celiprolol Delays the Onset of VEDS-related Clinical Events abstract has been accepted to the poster session.
The one-day in-person meeting will be held on Monday, August 29, 2022, from 8:00am – 5:00 pm in Paris, France, as part of The Marfan Foundation’s Science in Paris meeting. Follow the conference link (below) to learn more.
Conference Details
Website: https://thevedsmovement.org/
7 min read
ASCO 2026: Next-Generation Immunotherapies
Jun 19, 2026 Rachel Abu Taleb
A look at where personalized mRNA cancer vaccines, in vivo CAR-T and TIL therapies stand after this year’s meeting
...